Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000775
HKD
0.12
0 (-2.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-52.00
32.00
33.00
95.00
47.00
56.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
89.00
-32.00
-21.00
-59.00
-165.00
25.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
150.00
23.00
60.00
71.00
-83.00
117.00
Cash Flow from Investing Activities
87.00
-127.00
37.00
28.00
-184.00
-44.00
Cash Flow from Financing Activities
-328.00
6.00
-7.00
-26.00
42.00
-38.00
Net Cash Inflow / Outflow
-91.00
-96.00
90.00
73.00
-225.00
33.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-52.6622858355493
-69.328
17.00
24.04%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
89.2747103077744
30.473
59.00
192.96%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
150.096949984641
14.42
136.00
940.89%
Cash Flow from Investing Activities
87.2260456604793
-20.376
107.00
528.08%
Cash Flow from Financing Activities
-328.495621851659
-15.311
-313.00
-2045.49%
Net Cash Inflow / Outflow
-91.172626206539
-20.88
-71.00
-336.65%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.387
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 525.54% vs -60.23% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
150.10
23.99
525.54%